Literature DB >> 19700130

Prolonged electrocardiogram QRS duration independently predicts long-term mortality in patients hospitalized for heart failure with preserved systolic function.

Scott L Hummel1, Stephen Skorcz, Todd M Koelling.   

Abstract

BACKGROUND: Prolonged electrocardiogram (ECG) QRS duration (>or=120 ms) is a risk factor for death in systolic heart failure, but its effects in heart failure with preserved systolic function (HFPSF) have not been extensively studied. We hypothesized that prolonged ECG QRS duration would independently predict long-term mortality in hospitalized HFPSF patients. METHODS AND
RESULTS: We analyzed 872 HFPSF patients (defined as left ventricular ejection fraction >or=50%) admitted to Michigan community hospitals between 2002 and 2004 and followed for a median of 660 days. We used Cox proportional hazards models to assess mortality hazard for prolonged QRS duration (>or=120 ms) on the last available predischarge ECG, first on a univariable basis and then after multivariable adjustment for other known risk factors. Prolonged QRS duration increased univariable all-cause mortality (HR 1.71; 95% CI 1.33-2.19, P < .001) and after multivariable adjustment (HR 1.31; 95% CI 1.01-1.71, P=.04). The univariable effect size was larger in younger patients. In multivariable models, there was no significant interaction between prolonged QRS and age, hypertension, or coronary artery disease status.
CONCLUSIONS: Prolonged QRS duration (>or=120 ms) on a predischarge ECG is an independent and consistent predictor of long-term mortality in hospitalized HFPSF patients.

Entities:  

Mesh:

Year:  2009        PMID: 19700130      PMCID: PMC3769218          DOI: 10.1016/j.cardfail.2009.02.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  44 in total

1.  Trends in prevalence and outcome of heart failure with preserved ejection fraction.

Authors:  Theophilus E Owan; David O Hodge; Regina M Herges; Steven J Jacobsen; Veronique L Roger; Margaret M Redfield
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

2.  Comparison of six-month outcomes and hospitalization rates in heart failure patients with and without preserved left ventricular ejection fraction and with and without intraventricular conduction defect.

Authors:  Sorin C Danciu; Joaquin Gonzalez; Nirav Gandhi; Srikanth Sadhu; Cesar J Herrera; Richard Kehoe
Journal:  Am J Cardiol       Date:  2005-11-21       Impact factor: 2.778

Review 3.  Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy.

Authors:  Jianwen Wang; Karla M Kurrelmeyer; Guillermo Torre-Amione; Sherif F Nagueh
Journal:  J Am Coll Cardiol       Date:  2006-11-01       Impact factor: 24.094

Review 4.  Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.

Authors: 
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

5.  Baseline echocardiographic characteristics of heart failure patients enrolled in a large European multicentre trial (CArdiac REsynchronisation Heart Failure study).

Authors:  Stefano Ghio; Nick Freemantle; Alessandra Serio; Giulia Magrini; Laura Scelsi; Michele Pasotti; John G F Cleland; Luigi Tavazzi
Journal:  Eur J Echocardiogr       Date:  2005-12-05

6.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

7.  Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

Authors:  Clyde W Yancy; Margarita Lopatin; Lynne Warner Stevenson; Teresa De Marco; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

8.  Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

Authors:  Ali Ahmed; Michael W Rich; Jerome L Fleg; Michael R Zile; James B Young; Dalane W Kitzman; Thomas E Love; Wilbert S Aronow; Kirkwood F Adams; Mihai Gheorghiade
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

9.  Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.

Authors:  Mihai Gheorghiade; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Lilin She; Wendy Gattis Stough; Clyde W Yancy; James B Young; Gregg C Fonarow
Journal:  JAMA       Date:  2006-11-08       Impact factor: 56.272

10.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

View more
  9 in total

1.  Impact of prior admissions on 30-day readmissions in medicare heart failure inpatients.

Authors:  Scott L Hummel; Prashanth Katrapati; Brenda W Gillespie; Anthony C Defranco; Todd M Koelling
Journal:  Mayo Clin Proc       Date:  2014-03-29       Impact factor: 7.616

2.  Heart failure with a normal ejection fraction (HFNEF): embracing complexity.

Authors:  Mathew S Maurer
Journal:  J Card Fail       Date:  2009-06-13       Impact factor: 5.712

3.  QRS duration and cardiovascular mortality in Asian patients with heart failure and preserved and reduced ejection fraction.

Authors:  Jonathan Yap; Yann Shan Keh; Tong Shen; Carolyn S P Lam; Shaw Yang Chia; Fazlur Rehman Jaufeerally; Wilson Ong; David Sim; Chi-Keong Ching
Journal:  Cardiol J       Date:  2020-03-24       Impact factor: 2.737

4.  ECG in patients with acute heart failure can predict in-hospital and long-term mortality.

Authors:  Jan Václavík; Jindřich Špinar; David Vindiš; Jiří Vítovec; Petr Widimský; Čestmír Číhalík; Aleš Linhart; Filip Málek; Miloš Táborský; Ladislav Dušek; Jiří Jarkovský; Marián Fedorco; Marián Felšöci; Roman Miklík; Jiří Pařenica
Journal:  Intern Emerg Med       Date:  2012-10-06       Impact factor: 3.397

5.  The association of QRS duration with atrial fibrillation in a heart failure with preserved ejection fraction population: a pilot study.

Authors:  Joseph N Gigliotti; Mandeep S Sidhu; Alina M Robert; Jonathan S Zipursky; Jeremiah R Brown; Salvatore P Costa; Robert T Palac; David A Steckman; David J Malenka; Alan T Kono; Mark L Greenberg
Journal:  Clin Cardiol       Date:  2017-06-06       Impact factor: 2.882

6.  Prolonged QRS independently predicts long-term all-cause mortality in patients with narrow QRS complex undergoing coronary artery bypass grafting surgery (9-year follow-up results).

Authors:  Turan Erdoğan; Mustafa Çetin; Ali Gökhan Özyıldız; Savaş Özer; Abdülkadir Uslu; Sedat Ozan Karakişi; Tuncay Kırış
Journal:  Kardiochir Torakochirurgia Pol       Date:  2020-09-23

7.  Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.

Authors:  Gül Erdemli; Albert M Kim; Haisong Ju; Clayton Springer; Robert C Penland; Peter K Hoffmann
Journal:  Front Pharmacol       Date:  2012-01-26       Impact factor: 5.810

8.  Electrocardiographic characteristics in patients with heart failure and normal ejection fraction: A systematic review and meta-analysis.

Authors:  Theodora Nikolaidou; Nathan A Samuel; Carl Marincowitz; David J Fox; John G F Cleland; Andrew L Clark
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-10-11       Impact factor: 1.468

9.  Ventricular repolarization indicators in risk stratification of decompensated heart failure patients with ventricular systolic dysfunction.

Authors:  Mohammad Reza Hatamnejad; Hamed Bazrafshan; Morteza Hosseinpour; Peyman Izadpanah; Mohammad Reza Kasravi; Mehdi Bazrafshan
Journal:  Caspian J Intern Med       Date:  2022
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.